Tsunehiko Nishimura
About
In The Last Decade
Tsunehiko Nishimura
383 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 144
- Radiology, Nuclear Medicine and Imaging 3.9k
- Cardiology and Cardiovascular Medicine 1.6k
- Pulmonary and Respiratory Medicine 1.3k
- Surgery 1.2k
- Epidemiology 673
Countries citing papers authored by Tsunehiko Nishimura
This map shows the geographic impact of Tsunehiko Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsunehiko Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsunehiko Nishimura more than expected).
Fields of papers citing papers by Tsunehiko Nishimura
This network shows the impact of papers produced by Tsunehiko Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsunehiko Nishimura. The network helps show where Tsunehiko Nishimura may publish in the future.
Co-authorship network of co-authors of Tsunehiko Nishimura
This figure shows the co-authorship network connecting the top 25 collaborators of Tsunehiko Nishimura. A scholar is included among the top collaborators of Tsunehiko Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsunehiko Nishimura. Tsunehiko Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 13 | |
| 3 | 8 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 42 | |
| 7 | 8 | |
| 8 | [Diagnosis of coronary artery disease by thallium-201 myocardial scintigraphy with intravenous infusion of SUNY4001 (adenosine) in effort angina pectoris--the clinical trial report at multi-center: phase II]. | 5 |
| 9 | 16 | |
| 10 | 36 | |
| 11 | 9 | |
| 12 | 12 | |
| 13 | 20 | |
| 14 | [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases]. | 4 |
| 15 | 36 | |
| 16 | 16 | |
| 17 | 10 | |
| 18 | [Clinical significance of right ventricular ejection fraction in cases with atrial septal defect]. | 1 |
| 19 | -305-CARDIAC RESPONSE TO EXERCISE IN PATIENTS WITH CORONARY ARTERY DISEASE ASSESSED BY CARDIOPULMONARY EXERCISE TEST WITH AN AMBULATORY LEFT VENTRICULAR FUNCTION MONITORING DEVICE : Excercise Test : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY | 1 |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.